Bowen Xie

8PUBLICATIONS
47CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2026
Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections.

|Jun 17, 2026
ADAR1 deficiency in pancreatic cancer cells potentiates cDC1 activation and promotes sensitization to immunotherapy.

|Feb 06, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Birui Pan, Qinli Sun, Ruifeng Li

|Nov 13, 2025
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

Bowen Xie, Bowen Yuan, Xiaohong Zhao

|Aug 05, 2025
Ciliated cell-derived IL-17D restrains allergic asthma through controlling monocyte recruitment.

Lei Yuan, Jinling Huang, Jianhui Chen

|Oct 20, 2023
BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.

Qinli Sun, Dongli Cai, Dingfeng Liu

Pageof 2

Frequent Collaborators

8 joint publications

Chen Dong

6 joint publications

Peng Wei

6 joint publications

Qinli Sun

4 joint publications

Yongzhen Chen